Proliferation of endothelial cells on surface-immobilized albumin- heparin conjugate loaded with basic fibroblast growth factor

Journal of Biomedical Materials Research

Volumn 44, Issue 3, 1999, Pages 330-340

  Bos, Gert W ^a   Scharenborg, Nicole M ^a   Poot, André A ^a   Engbers, Gerard H M ^a   Beugeling, Tom ^a   Van Aken, Willem G ^a   Feijen, Jan ^a  

^a UNIVERSITY OF TWENTE   (Netherlands)

Author keywords

Albumin heparin conjugate; Basic fibroblast growth factor (bFGF); Endothelial cell seeding; Small diameter vascular grafts; Stability

Indexed keywords

BIODEGRADATION; CELL CULTURE; CELL IMMOBILIZATION; CHEMICAL BONDS; COMPLEXATION; IODINE; POLYSTYRENES; PROSTHETICS;

ALBUMIN; BASIC FIBROBLAST GROWTH FACTOR; HEPARIN;

GRAFTS;

ALBUMIN; BASIC FIBROBLAST GROWTH FACTOR; HEPARIN;

ARTICLE; BIOCOMPATIBILITY; BLOOD VESSEL DIAMETER; BLOOD VESSEL GRAFT; CELL PROLIFERATION; ENDOTHELIUM CELL; GRAFT OCCLUSION; GROWTH STIMULATION; HUMAN; HUMAN CELL; UMBILICAL VEIN; VASCULAR ENDOTHELIUM;

BLOOD VESSEL PROSTHESIS; CARBON DIOXIDE; CELL CULTURE TECHNIQUES; CELL DIVISION; CELLS, CULTURED; CULTURE MEDIA; ENDOTHELIUM, VASCULAR; FIBROBLAST GROWTH FACTOR 2; FIBRONECTINS; HEPARIN; HUMANS; IODINE RADIOISOTOPES; MICROSPHERES; OLIGOPEPTIDES; POLYSTYRENES; RECEPTORS, FIBRONECTIN; RECEPTORS, VITRONECTIN; RECOMBINANT FUSION PROTEINS; SEPHAROSE; SERUM ALBUMIN; STERILIZATION; SULFUR RADIOISOTOPES;

EID: 0033525433     PISSN: 00219304     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4636(19990305)44:3<330::AID-JBM12>3.0.CO;2-O     Document Type: Article

References (45)

1. Schmidt SP, Shar WV, Evancho MM, Meerbaum SO. Endothelial cell seeding of prosthetic vascular grafts - Current status. In: Szycher M, editor. High performance biomaterials. Lancaster, Pennsylvania: Technomic Publishing Company, Incl; 1991. p 483-496.
2. Szilagyi DE, Elliot JP, Smith RF, Reddy DJ, McPharlin M. A thirty-year survey of the reconstructive surgical treatment of aortoiliac occlusive disease. J Vasc Surg 1986;3:421-436.
3. Antiplatelet Trialist's Collaboration. Collaborative overview of randomised trials of antiplatelet therapy. II. Maintenance of vascular graft or arterial patency by antiplatelet therapy. Brit Med J 1994;308:159-168.
4. Yeager A, Callow AD. New graft materials and current approaches to an acceptable small diameter vascular graft. Trans Am Soc Artif Intern Org 1988;34:88-94.
5. Uchida N, Kambic H, Emoto H, Chen J-F, Hsu S, Murabachi S, Harasaki H, Nose Y. Compliance effects on small diameter polyurethane graft patency. J Biomed Mater Res 1993;27:1269-1279.
6. Kodama M. Small-diameter cardiovascular graft. Proc Jpn Cong Mater Res 1990;33:153-155.
7. Sauvage LR, Berger K, Beilin LB, Smith JC, Wood SJ, Mansfield PB. Presence of endothelium in an axillary-femoral graft of knitted dacron with an external velour surface. Ann Surg 1975; 182:749-753.
8. Davies MG, Hagen PO. The vascular endothelium - A new horizon. Ann Surg 1993;218:593-609.
9. Wu KK, Fraisier-Scott K, Hadzakis H. Endothelial cell function in hemostasis and thrombosis. Adv Exp Med Biol 1988;242: 127-133.
10. Wu MHD, Shi Q, Wechezak AR, Clowes AW, Gordon IL, Sauvage LR. Definitive proof of endothelialization of a dacron arterial prosthesis in a human being. J Vasc Surg 1995;21:862-867.
11. Örtenwall P, Wadenvik H, Kutti J, Risberg B. Endothelial cell seeding reduces thrombogenicity of Dacron grafts in humans. J Vasc Surg 1990;11:403-410.
12. James NL, Schindhelm K, Slowiaczek P, Milthorpe BK, Dudman NPB, Johnson G, Steele JG. Endothelial cell seeding of small diameter vascular grafts. Artif Org 1990;14:355-360.
13. Zilla P, Deutsch M, Meinhart J, Puschmann R, Eberl T, Minar E, Dudcazk R, Lugmaier H, Schmid P, Noszian I, Fischlein T. Clinical in vitro endothelialization of femoropopliteal bypass grafts: An actuarial follow-up over three years. J Vasc Surg 1994;19:540-548.
14. Meinhart J, Deutsch M, Zilla P. Eight years of clinical endothelial cell transplantation - Closing the gap between prosthetic grafts and vein grafts. Am Soc Artif Intern Org 1997;43:M515-M521.
15. Bos GW, Scharenborg NM, Poot AA, Engbers GHM, Terlingen JGA, Beugeling T, van Aken WG, Feijen J. Adherence and proliferation of endothelial cells on surface-immobilized albumin-heparin conjugate. Tissue Eng. To appear.
16. Bos GW, Scharenborg NM, Poot AA, Engbers GHM, Terlingen JGA, Beugeling T, van Aken WG, Feijen J. Adherence and proliferation of endothelial cells on surface-immobilized albumin-heparin conjugate. In: Bos GW, editor. Albumin-heparin matrices loaded with growth factor as substrates for endothelial cell seeding. Enschede, The Netherlands: Thesis University of Twente; 1998.
17. Burgess WH, Maciag T. The heparin-binding (fibroblast) growth factor family of proteins. Ann Rev Biochem 1989;58: 575-606.
18. Baird A, Walicke PA. Fibroblast growth factors. Br Med Bull 1989;45:438-452.
19. Pepper MS, Ferrara N, Orci L, Montesano R. Potent synergism between vascular endothelial growth factor and basic fibroblast growth factor in the induction of angiogenesis in vitro. Biochem Biophys Res Commun 1992;189:824-831.
20. Neufeld G, Gospodarowicz D. Basic and acidic fibroblast growth factors interact with the same cell surface receptors. J Biol Chem 1986;261:5631-5637.
21. Pantaliano MW, Holick RA, Springer BA, van Dyk DE, Tobery T, Wetmore DR, Lear JD, Nahapetian AT, Bradley JD, Sisk WP. Multivalent ligand-receptor binding interactions in the fibroblast growth factor system produce a cooperative growth factor and heparin mechanism for receptor dimerization. Biochem 1994;33:10229-10248.
22. Saksela O, Moscatelli D, Sommer A, Rifkin DB. Endothelial cell derived heparan sulfate binds basic fibroblast growth factor and protects it from proteolytic degradation. J Cell Biol 1988; 107:743-751.
23. Vlodavski I, Fuks Z, Ishai-Michaeli R, Bashkin P, Levi E, Korner G, Bar-Shavit R, Klagsbrun M. Extracellular matrix-resident basic fibroblast growth factor: Implication for the control of angiogenesis. J Cell Biochem 1991;45:167-176.
24. Prestrelski SJ, Fox GM, Arakawa T. Binding of heparin to basic fibroblast growth factor induces a conformational change. Arch Biochem Biophys 1992;293:314-319.
25. Sommer A, Rifkin DB. Interaction of heparin with human basic fibroblast growth factor: Protection of the angiogenic protein from proteolytic degradation by a glycosamino-glycan. J Cell Phys 1989;138:215-220.
26. Soldani G, Steiner M, Galletti PM, Lelli L, Palla M, Giusti P. Development of small-diameter vascular prostheses which release bioactive agents. Clin Mater 1991;8:81-88.
27. Gray JL, Kang SS, Zenni GC, Kim DU, Kim PI, Burgess WH, Drohan W, Winkles JA, Haudenschild CC, Greisler HP. FGF-1 affixation stimulates ePTFE endothelialization without intimal hyperplasia. J Surg Res 1994;57:596-612.
28. Greisler HP. Growth factor release from vascular grafts. J Controlled Release 1996;39:267-280.
29. Greisler HP, Gosselin C, Reen D, Kang SS, Kim DU. Biointer-active polymers and tissue engineered blood vessels. Biomaterials 1996;17:329-336.
30. Doi K, Matsuda T. Enhanced vascularization in a microporous polyurethane graft impregnated with basic fibroblast growth factor and heparin. J Biomed Mater Res 1997;34:361-370.
31. Teft J, Roskos KV, Heller J. Development of hydrogel-containing stabilized basic fibroblast growth factor for wound treatment. Kopacek J, editor. Proceedings of the 19th International Symposium of Controlled Release Bioactive Materials. Deerfield, Illinois: Controlled Release Society; 1992. p 371-372.
32. Thompson JA, Haudenschild CC, Anderson KD, DiPietro JM, Anderson WF, Maciag T. Heparin-binding growth factor 1 induces the formation of organoid neovascular structures in vivo. Proc Natl Acad Sci USA 1989;86:7928-7932.
33. Fischlein T, Lehner G, Lante W, Fittkau M, Murphy JG, Weinhold C, Reichart B. Endothelialization of cardiac valve bioprostheses. Int J Artif Org 1994;17:345-352.
34. Markwell MAK. A new solid-state reagent to iodinate proteins: Conditions for the efficient labeling of antiserum. Anal biochem 1982;125:427-432.
35. Bos GW, Scharenborg NM, Poot AA, Engbers GHM, Beugeling T, van Aken WG, Feijen J. Endothelialization of crosslinked albumin-heparin gels. In: Bos GW, editor. Albumin-heparin matrices loaded with growth factor as substrates for endothelial cell seeding. Enschede, The Netherlands: Thesis University of Twente; 1998.
36. Jaffe EA, Nachman RL, Becker CG, Miniick CR. Culture of human endothelial cells derived from umbilical cord veins. Identification by morphologic and immunologic criteria. J Clin Invest 1973;52:2745-2756.
37. Gospodarowicz D, Neufeld G, Schweigerer L. Molecular and biological characterization of fibroblast growth factor, an angiogenic factor which also controls the proliferation and differentiation of mesoderm and neuroectoderm-derived cells. Cell Diff 1986;19:1-17.
38. Gospodarowicz D, Vlodavski I, Savion N. The role of fibroblast growth factor and the extracellular matrix in the control of proliferation and differentiation of corneal endothelial cells. Vis Res 1981;21:87-103.
39. Yamamura K, Sakurai T, Yano K, Nabeshima T, Yotsuyanagi T. Sustained release of basic fibroblast growth factor from the synthetic prosthesis using hydroxypropylchitosan acetate. J Biomed Mater Res 1995;29:203-206.
40. Albes JM, Klenzner T, Kotzerke J, Thiedemann KU, Schäfers HJ, Borst HG. Improvement of tracheal autograft revascularization by means of fibroblast growth factor. Ann Thorac Surg 1994;57:444-449.
41. Galzie Z, Fernig DG, Smith JA, Poston GJ, Kinsella AR. Invasion of human colorectal carcinoma cells is promoted by endogenous basic fibroblast growth factor. Int J Cancer 1997;71: 390-395.
42. Stanford FG. Stability of compounds labeled with iodine-125 or -131. Amersham. The Radiochemical Centre Limited. TRC report 354; 1974. 18 p.
43. Wissink MJB. University of Twente. Personal communication.
44. Linemayer DL, Kelly LJ, Menke JG, Giminez-Gallego G, DiSalvo J, Thomas KA. Expression in Escherichia coli of a chemically synthesized gene for biologically active bovine fibroblast growth factor. Biotechnology 1987;5:960-965.
45. Brash JL. Role of plasma protein adsorption in the response of blood to foreign surfaces. In: Sharma CP, Szycher M, editors. Bloodcompatible materials and devices - perspectives towards the 21st century. Lancaster, Pennsylvania: Technomic Publishing Company; 1991. p 3-24.